+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Alzheimer's Disease Global Clinical Trials Review, H1, 2020

  • PDF Icon

    Clinical Trials

  • 1130 Pages
  • May 2020
  • Region: Global
  • GlobalData
  • ID: 5118398
Summary

The publisher's clinical trial report, “Alzheimer's Disease Global Clinical Trials Review, H1, 2020" provides an overview of Alzheimer's Disease Clinical trials scenario. This report provides top line data relating to the clinical trials on Alzheimer's Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). The publisher's Clinical Trial Reports are generated using the publisher's proprietary database - Pharma - Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Scope
  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to Buy
  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Report Guidance
Clinical Trials Report Coverage
  • Clinical Trials by Region
  • Clinical Trials and Average Enrollment by Country
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
  • Top Five Countries Contributing to Clinical Trials in Europe
  • Top Countries Contributing to Clinical Trials in North America
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
  • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Alzheimer's Disease to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Alzheimer's Disease to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status

Clinical Trials by Phase
  • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time

Clinical Trials by Sponsor Type
  • Prominent Sponsors
  • Top Companies Participating in Alzheimer's Disease Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Alzheimer's Disease
  • Mar 09, 2020: Study shows Nilvadipine slows early-stage Alzheimer’s disease
  • Mar 05, 2020: AC Immune to present new data on neurodegenerative program ACI-35.030 at the Upcoming Advances in Alzheimer’s and Parkinson’s Therapies Focus Meeting
  • Mar 03, 2020: Alzheimer patients at Swedish clinics to be included in Phase 3 study of drug candidate BAN2401
  • Feb 27, 2020: Inflazome’s Somalix demonstrates positive safety, tolerability and pharmacodynamic profile in its phase I study
  • Feb 26, 2020: ProMIS Neurosciences initiates natural history study of blood-based biomarkers in Alzheimer’s Disease
  • Feb 20, 2020: Annovis issued patent for method of treating Parkinson’s Disease and other lewy body diseases
  • Feb 14, 2020: Annovis Bio to continue DISCOVER Alzheimer’s trial
  • Feb 12, 2020: Oligomerix presents preclinical data at TAU2020 Global Conference for small molecule inhibitor of tau self-association
  • Feb 11, 2020: Cassava Sciences announces Phase 2a study of PTI-125 published in the Journal of Prevention of Alzheimer’s Disease (JPAD)
  • Feb 11, 2020: T3D Therapeutics begins enrollment in the PIONEER Phase 2 clinical trial of T3D-959 in patients with mild to moderate alzheimer's disease
  • Clinical Trial Profile Snapshots

Appendix
  • Abbreviations
  • Definitions
  • Research Methodology
  • Secondary Research
  • About the Publisher
  • Contact
  • Source

List of Tables
  • Alzheimer's Disease Therapeutics, Global, Clinical Trials by Region, 2020*
  • Alzheimer's Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2020*
  • Alzheimer's Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2020*
  • Alzheimer's Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2020*
  • Alzheimer's Disease Therapeutics Clinical Trials, Europe, Top Five Countries, 2020*
  • Alzheimer's Disease Therapeutics Clinical Trials, North America, Top Countries, 2020*
  • Alzheimer's Disease Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2020*
  • Alzheimer's Disease Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2020*
  • Proportion of Alzheimer's Disease to Central Nervous System Clinical Trials, G7 Countries (%), 2020*
  • Alzheimer's Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2020*
  • Alzheimer's Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2020*
  • Proportion of Alzheimer's Disease to Central Nervous System Clinical Trials, E7 Countries (%), 2020*
  • Alzheimer's Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2020*
  • Alzheimer's Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2020*
  • Alzheimer's Disease Therapeutics, Global, Clinical Trials by Phase, 2020*
  • Alzheimer's Disease Therapeutics, Global, Clinical Trials In Progress by Phase 2020*
  • Alzheimer's Disease Therapeutics, Global, Clinical Trials by Trial Status, 2020*
  • Alzheimer's Disease Therapeutics Clinical Trials, Global, by End Point Status, 2020*
  • Alzheimer's Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2015-2019
  • Alzheimer's Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2020*
  • Alzheimer's Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2020*
  • Alzheimer's Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2020*
  • Alzheimer's Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2020*

List of Figures
  • Alzheimer's Disease Therapeutics, Global, Clinical Trials by Region (%), 2020*
  • Alzheimer's Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2020*
  • Alzheimer's Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2020*
  • Alzheimer's Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2020*
  • Alzheimer's Disease Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2020*
  • Alzheimer's Disease Therapeutics Clinical Trials, North America, Top Countries (%), 2020*
  • Alzheimer's Disease Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2020*
  • Alzheimer's Disease Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2020*
  • Proportion of Alzheimer's Disease to Central Nervous System Clinical Trials, G7 Countries (%), 2020*
  • Alzheimer's Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2020*
  • Alzheimer's Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2020*
  • Proportion of Alzheimer's Disease to Central Nervous System Clinical Trials, E7 Countries (%), 2020*
  • Alzheimer's Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2020*
  • Alzheimer's Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2020*
  • Alzheimer's Disease Therapeutics, Global, Clinical Trials by Phase (%), 2020*
  • Alzheimer's Disease Therapeutics, Global, Clinical Trials In Progress by Phase, 2020*
  • Alzheimer's Disease Therapeutics, Global, Clinical Trials by Trial Status, 2020*
  • Alzheimer's Disease Therapeutics Clinical Trials, Global, by End Point Status, 2020*
  • Alzheimer's Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2015-2019
  • Alzheimer's Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2020*
  • Alzheimer's Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2020*
  • Alzheimer's Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2020*
  • Alzheimer's Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2020*
  • Methodology

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Pfizer Inc
  • Johnson & Johnson
  • Eisai Co Ltd
  • F. Hoffmann-La Roche Ltd
  • Eli Lilly and Co
  • Novartis AG
  • AstraZeneca Plc
  • Allergan Plc
  • GlaxoSmithKline Plc
  • The Lundbeck Foundation